It also feels like with statins, that the standard of when to take the drug is some kind of Overton window. If the FDA rules that that it's worthwhile for people with diabetes, then it gets prescribed for people at risk of diabetes, then for people at risk of pre-diabetes, then it gets prescribed for people who may be at risk of pre-diabetes, then it gets prescribed for people wanting to be precautious of potentially being at risk for pre-diabetes, and so forth.